• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风疹免疫力状况以及孕期主动提供 MMR/MMRV 疫苗接种。

Rubella immunity status and the active offer of MMR/MMRV vaccination during pregnancy.

机构信息

Servizio Epidemiologia Clinica e Valutativa, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Servizio Patologia Clinica, Ospedale S. Chiara, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

出版信息

Ann Ist Super Sanita. 2021 Jan-Mar;57(1):26-32. doi: 10.4415/ANN_21_01_04.

DOI:10.4415/ANN_21_01_04
PMID:33797401
Abstract

INTRODUCTION

The rubella test during pregnancy makes it possible to identify situations at risk of congenital rubella and those pregnant mothers who should be offered the MMR vaccine.

MATERIALS AND METHODS

The Authors analysed test coverage and the immunity status of pregnant mothers between 2005 and 2017, using birth attendance certificates.

RESULTS

Rubella test coverage on 61,437 pregnant mothers was 99.4%. The average proportion of susceptible subjects was 6.4%. Seroconversion was observed in 7 cases, with 1 confirmed case of congenital rubella. 32% of susceptible subjects were vaccinated, and adherence was seen to be influenced by the characteristics of the pregnant women and of the maternity unit.

CONCLUSIONS

A current information flow including a number of healthcare services, is useful both for monitoring the maternity care pathway and for public health purposes.

摘要

简介

怀孕期间的风疹检测可识别出先天性风疹感染的风险情况,以及那些应接种 MMR 疫苗的孕妇。

材料与方法

作者使用分娩登记证分析了 2005 年至 2017 年期间的检测覆盖率和孕妇的免疫状况。

结果

61437 名孕妇的风疹检测覆盖率为 99.4%。易感人群的平均比例为 6.4%。7 例发生血清转化率,1 例确诊为先天性风疹。32%的易感人群接受了疫苗接种,其接种依从性受到孕妇和产科单位特征的影响。

结论

当前包括多个医疗保健服务在内的信息流动,对于监测产妇保健途径和公共卫生都很有用。

相似文献

1
Rubella immunity status and the active offer of MMR/MMRV vaccination during pregnancy.风疹免疫力状况以及孕期主动提供 MMR/MMRV 疫苗接种。
Ann Ist Super Sanita. 2021 Jan-Mar;57(1):26-32. doi: 10.4415/ANN_21_01_04.
2
Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.一种减毒活四价麻疹-腮腺炎-风疹-水痘(MMRV)疫苗的反应原性和免疫原性。
Vaccine. 2002 Dec 13;21(3-4):281-9. doi: 10.1016/s0264-410x(02)00459-0.
3
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).使用麻疹、腮腺炎、风疹和水痘联合疫苗:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.
4
Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.在健康儿童生命的第二年,对一剂和两剂冰箱保存稳定的四价麻疹-腮腺炎-风疹-水痘疫苗后的免疫原性和安全性评估。
Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22.
5
Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.四价麻疹、腮腺炎、风疹和水痘疫苗(MMRV)在健康儿童中的免疫原性和反应原性:一项随机对照试验的荟萃分析。
Expert Rev Vaccines. 2015;14(8):1149-57. doi: 10.1586/14760584.2015.1057572. Epub 2015 Jun 16.
6
The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.一种四价麻疹、腮腺炎、风疹和水痘疫苗在健康儿童中的安全性和免疫原性:生产一致性及抗体持久性研究
Pediatr Infect Dis J. 2006 Jul;25(7):615-22. doi: 10.1097/01.inf.0000220209.35074.0b.
7
Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.健康儿童接种两剂四价麻疹-腮腺炎-风疹-水痘疫苗后 3 年的抗体持久性。
Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21.
8
A combination vaccine against measles, mumps, rubella and varicella.一种针对麻疹、腮腺炎、风疹和水痘的联合疫苗。
Drugs Today (Barc). 2008 Apr;44(4):279-92. doi: 10.1358/dot.2008.44.4.1210755.
9
The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.四价麻疹-腮腺炎-风疹-水痘疫苗与结合型C群脑膜炎球菌疫苗联合接种于健康儿童时的免疫原性和安全性:意大利一项IIIb期、随机、多中心研究
Vaccine. 2016 Aug 5;34(36):4278-84. doi: 10.1016/j.vaccine.2016.07.009. Epub 2016 Jul 14.
10
Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.两剂次四价麻疹-腮腺炎-风疹-水痘疫苗在健康儿童中的免疫原性和安全性
Pediatr Infect Dis J. 2006 Jan;25(1):12-8. doi: 10.1097/01.inf.0000195626.35239.58.

引用本文的文献

1
Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China.中国杭州实施风疹疫苗全国接种 12 年后风疹按年龄组的流行病学特征。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2054208. doi: 10.1080/21645515.2022.2054208. Epub 2022 Mar 28.